证 券 研 究 报 告 时代天使（06699.HK）深度研究报告 推荐（首次） 国产隐形正畸龙头——本土崛起，出海破局 国产隐形正畸龙头：本土崛起，出海破局。公司是中国领先的口腔隐形正畸技 术、隐形矫治器生产及销售的服务提供商。从 2021 年起，公司在国内市场的 案例数份额反超隐适美，成为国内第一，近些年其国内业绩在行业环境承压下 表现稳健。海外业务的快速增长拉动了公司总体营收的增长，2024 年海外市 场案例已达约 14.07 万例，同比增长 326%；2025H1 海外市场案例进一步大幅 增长至 11.72 万例（+104%），占公司总案例的 52%，已超过国内案例数。并且 随着收入起量，预计海外业务的盈利时点将近，后续有望带动利润端快速增长。 关键问题 1：国内业务成长性如何？ 1）全球市场数倍于国内，打开成长天花板。全球隐形正畸市场案例数是国内 的 8 倍。在渗透率较高的美国，公司仍有机会通过优质的产品技术、服务和价 格优势进行突破，欧洲、亚太、拉美等市场渗透率有较大提升空间。 2）全方位竞争优势赋能出海征程，全球份额显著提高。a、在产品力方面，公 司拥有全面的产品体系，并通过持续研发创新推动产品力 ...

证 券 研 究 报 告 时代天使（06699.HK）深度研究报告 推荐（首次） 国产隐形正畸龙头——本土崛起，出海破局 国产隐形正畸龙头：本土崛起，出海破局。公司是中国领先的口腔隐形正畸技 术、隐形矫治器生产及销售的服务提供商。从 2021 年起，公司在国内市场的 案例数份额反超隐适美，成为国内第一，近些年其国内业绩在行业环境承压下 表现稳健。海外业务的快速增长拉动了公司总体营收的增长，2024 年海外市 场案例已达约 14.07 万例，同比增长 326%；2025H1 海外市场案例进一步大幅 增长至 11.72 万例（+104%），占公司总案例的 52%，已超过国内案例数。并且 随着收入起量，预计海外业务的盈利时点将近，后续有望带动利润端快速增长。 关键问题 1：国内业务成长性如何？ 1）全球市场数倍于国内，打开成长天花板。全球隐形正畸市场案例数是国内 的 8 倍。在渗透率较高的美国，公司仍有机会通过优质的产品技术、服务和价 格优势进行突破，欧洲、亚太、拉美等市场渗透率有较大提升空间。 2）全方位竞争优势赋能出海征程，全球份额显著提高。a、在产品力方面，公 司拥有全面的产品体系，并通过持续研发创新推动产品力 ...

Core Viewpoint - Align Technology, the parent company of Invisalign, has initiated a series of patent infringement lawsuits against Angelalign in the US, Europe, and China, claiming infringement on core technologies related to multi-layer aligner materials, treatment planning, and aligner characteristics [1][3][15] Group 1: Legal Actions and Responses - Align Technology has filed lawsuits claiming Angelalign infringed on five US utility patents, including two material patents and three technology patents, which are crucial to Align's global intellectual property portfolio [3][15] - Angelalign has publicly denied the infringement allegations, stating they are "baseless" and has committed to actively defending against the lawsuits [1][2][5] - The legal actions reflect Align Technology's strategy to protect its intellectual property and reshape the competitive landscape to align with its research-driven development model [2][15] Group 2: Market Dynamics and Competitive Landscape - Angelalign has gained significant market share in China, reaching 41.9% in 2023, surpassing Align Technology by 10 percentage points [9][12] - Angelalign's revenue and net profit are projected to grow significantly, with a year-on-year increase of approximately 538.1% to 604.8% expected in the first half of 2025 [9][12] - Align Technology's performance in China has been declining, with revenue growth dropping from 90% in 2018 to less than 2% in 2020, indicating challenges in maintaining market presence [12][15] Group 3: Strategic Initiatives - Angelalign's strategy includes a tiered branding approach and partnerships to penetrate lower-tier cities, offering lower-priced products to attract price-sensitive consumers [13][15] - The company has expanded its international presence, with 39.1% of its cases now coming from outside China, and has established subsidiaries in key markets like the US and Europe [14][15] - Align Technology's reliance on high-margin structures is threatened by Angelalign's cost-effective and localized production strategies, which could disrupt traditional competitive advantages in the industry [15][16]